-
-
-
-
-
-
-
Guggenheim Defending Dianthus Therapeutics (DNTH): 'We reiterate our positive view'
-
-
-
-
-
-
-
Dianthus Therapeutics (DNTH) Misses Q1 EPS by 85c
-
-
-
-
-
-
-
Dianthus Therapeutics (DNTH) PT Raised to $98 at Jefferies
-
-
-
-
-
-
-
Dianthus Therapeutics (DNTH) Misses Q4 EPS by 143c
-
-
-
-
-
-
-
Dianthus Therapeutics (DNTH) files $600M mixed shelf
-
-
-
-
-
-
-
Guggenheim on Dianthus (DNTH) and Leads BioLabs Deal: 'We view this as a well-structured deal'
-
-
-
-
-
-
-
Guggenheim on Dianthus Therapeutics (DNTH): 'remains one of our Top Picks'
-
460,414 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

